Asís Ariznavarreta is named Leader of the Market & Patient Access Unit at Outcomes’10 in Spain (a PLG company)
His new role leading the Market & Patient Access unit at Outcomes’10 in Spain reinforces ProductLife Group’s commitment to strengthening strategic capabilities in an environment characterised by increasing assessment requirements and the ongoing evolution of healthcare evaluation and decision-making processes.
ProductLife Group (PLG), a global provider of services for the life sciences industry, has recently announced the appointment of Asís Ariznavarreta as Leader of the Market & Patient Access Unit at Outcomes’10 in Spain, at a time when demonstrating value is becoming increasingly important to support the adoption of healthcare innovation.
Access to innovation requires ever closer integration between scientific evidence, health outcomes and the needs of healthcare systems, in line with the evolving landscape of assessment and decision-making processes.
Asís Ariznavarreta holds a degree in Pharmacy from the University of Navarra and a Master's in Commercial Management and Marketing for the Pharmaceutical Industry from CESIF. He brings extensive experience in health economics, health economics and outcomes research (HEOR) and market access strategies. Throughout his career, he has developed expertise across both strategic consulting and the pharmaceutical industry, contributing to national and international projects focused on the design and implementation of market access strategies, including pricing and reimbursement processes, health technology assessment (HTA) and the development of economic evidence.
Since joining Outcomes’10 (a PLG company), he has held positions of increasing responsibility, progressively expanding his contribution to strategic national and international initiatives across the Group.
In this context, he has contributed to the design and leadership of complex market access and evidence-generation projects. His progression within the organisation reflects a steady expansion of responsibilities, supported by a combination of technical expertise, strategic vision, deep knowledge of the healthcare landscape and leadership of multidisciplinary teams.
In his new role, he will be responsible for driving the growth of the Market & Patient Access unit in Spain and strengthening capabilities in key areas such as market access, evidence generation and value positioning, in close coordination with other areas of the Group.
This appointment reflects ProductLife Group’s commitment to delivering integrated solutions across the entire product lifecycle, combining local expertise with global reach to support clients in the development, regulation and access of healthcare innovation.
Access to innovation: an evolving landscape in Spain
The current landscape in Spain is characterised by increasing requirements for health technology assessment and for demonstrating value for innovative therapies. Pricing and reimbursement processes are increasingly incorporating clinical, economic and health outcomes dimensions, reinforcing the need to integrate evidence generation with market access strategies from the earliest stages of development.
In this environment, the ability to translate evidence into value propositions aligned with healthcare system priorities is becoming a key differentiating factor in facilitating the adoption of new therapies.